Alexander Vos

Alexander Vos is currently Chairman at Scenic Biotech BV; Independent Director at Alpha Teknova, Inc. since 2021; Director at InnoCore Technologies BV; Director at Roslin Cell Therapies Ltd.; Member of the Supervisory Board at CiMaas BV since 2018; and Venture Partner at Biogeneration Management BV since 2019.
Former roles include Chief Executive Officer at PharmaCell BV from 2009 to 2017; Chief Executive Officer at MediService AG in 2004; Chief Executive Officer at VarmX BV from 2018 to 2021; Chief Executive Officer at VectorY BV from 2021 to 2022; Chairman of the Supervisory Board at Symeres BV from 2018 to 2021; Director at Alliance for Regenerative Medicine from 2015 to 2018; Chief Operating Officer at PAION AG from 2004 to 2013; Director-Business Development at Genzyme Therapeutics Ltd.; Director-Supervisory Board at Medisse BV; and Strategy Consultant at McKinsey & Co., Inc. Education includes undergraduate and graduate degrees from the University of Amsterdam and an MBA from Stanford Graduate School of Business.